de los Pinos Elisabet Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$1.03M

Insider Activity of de los Pinos Elisabet

According to the SEC Form 4 filings, de los Pinos Elisabet, being in a position of

  1. See Remarks at Aura Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 64576 shares for $323,369,
    over all time since 2022-10-31, has bought 0 shares, and sold 182587 shares for $1.41M.

Biography of de los Pinos Elisabet

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $323,3692100

Comparison of Insiders on Amount of Buys and Sells

2026-02-17SaleAura Biosciences, Inc.
AURA
See Remarks
47,648
0.0723%
$5.06$241,099+31.14%
2026-01-20SaleAura Biosciences, Inc.
AURA
See Remarks
16,928
0.0261%
$4.86$82,270+36.22%
2025-10-29SaleAura Biosciences, Inc.
AURA
See Remarks
9,049
0.0163%
$6.35$57,461+5.21%
2025-02-18SaleAura Biosciences, Inc.
AURA
See Remarks
20,221
0.0395%
$7.75$156,796-20%
2025-01-21SaleAura Biosciences, Inc.
AURA
See Remarks
15,955
0.0308%
$7.67$122,381-21.94%
2024-10-29SaleAura Biosciences, Inc.
AURA
See Remarks
9,200
0.0186%
$10.74$98,788-38.1%
2024-10-18SaleAura Biosciences, Inc.
AURA
See Remarks
24,992
0.0517%
$12.04$300,839-42.5%
2024-01-23SaleAura Biosciences, Inc.
AURA
See Remarks
15,853
0.0323%
$7.64$121,141+7.07%
2023-11-06SaleAura Biosciences, Inc.
AURA
See Remarks
7,449
0.0211%
$12.03$89,611-26.73%
2023-10-30SaleAura Biosciences, Inc.
AURA
See Remarks
9,586
0.0229%
$6.83$65,478+7.9%
2022-10-31SaleAura Biosciences, Inc.
AURA
See Remarks
5,706
0.0192%
$12.46$71,082-15.25%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.